Product NDC: | 0169-3687 |
Proprietary Name: | Levemir |
Non Proprietary Name: | insulin detemir |
Active Ingredient(s): | 14.2 mg/mL & nbsp; insulin detemir |
Administration Route(s): | SUBCUTANEOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0169-3687 |
Labeler Name: | Novo Nordisk |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021536 |
Marketing Category: | NDA |
Start Marketing Date: | 20060327 |
Package NDC: | 0169-3687-12 |
Package Description: | 1 VIAL, GLASS in 1 CARTON (0169-3687-12) > 10 mL in 1 VIAL, GLASS |
NDC Code | 0169-3687-12 |
Proprietary Name | Levemir |
Package Description | 1 VIAL, GLASS in 1 CARTON (0169-3687-12) > 10 mL in 1 VIAL, GLASS |
Product NDC | 0169-3687 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | insulin detemir |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | SUBCUTANEOUS |
Start Marketing Date | 20060327 |
Marketing Category Name | NDA |
Labeler Name | Novo Nordisk |
Substance Name | INSULIN DETEMIR |
Strength Number | 14.2 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Insulin [Chemical/Ingredient],Insulin Analog [EPC] |